Key Points GAAP revenue of $37.2 million missed expectations by 2.3% in Q2 2025. Acute Care segment revenue surged 55.5%, while Oncology segment revenue declined 9.0%. Full-year 2025 adjusted EBITDA ...

Revenue climbed 22% (GAAP) for the three months ended June 30, 2025, compared to the prior year period, largely due to international growth in the Vycor Medical division. Non-GAAP operating profit ...

WM Technology, Inc. (NASDAQ: MAPS) Q2 2025 Earnings Call Transcript August 7, 2025 WM Technology, Inc. misses on earnings ...

While the company exceeded analyst expectations on several fronts, its Q3 outlook includes softer revenue and a slide back ...

Backblaze just two quarters ago turned cash-flow-positive and expects to become GAAP net-income-positive within a few years, ...

Sees revenue $960M, plus or minus $40M, consensus $946.07M. Published first on TheFly – the ultimate source for real-time, market-moving breaking ...

Reports Q2 revenue $176.5M, consensus $168.97M. “Our second quarter results were strong, exceeding the high end of our outlook for both revenue ...

If misused, however, non-GAAP measures can present a distorted picture that’s more favorable than the company’s true results would indicate. The possibility that some companies were presenting a ...